The role of sleep disturbance in the associations of borderline personality disorder symptom severity to nonsuicidal self‐injury and suicide risk among patients with substance use disorders

Author(s):  
Kayla M. Scamaldo ◽  
Matthew T. Tull ◽  
Kim L. Gratz
2015 ◽  
Vol 146 ◽  
pp. e276-e277
Author(s):  
Lauren R. Few ◽  
Colleen A. Sloan ◽  
Nicholas G. Martin ◽  
Timothy J. Trull ◽  
Arpana Agrawal ◽  
...  

Author(s):  
Timothy J. Trull ◽  
Lindsey K. Freeman ◽  
Tayler J. Vebares ◽  
Alexandria M. Choate ◽  
Ashley C. Helle ◽  
...  

Until recently, borderline personality disorder (BPD) has been the stepchild of psychiatric disorders. Many researchers even questioned its existence. Clinicians have been reluctant to reveal the diagnosis to patients because of the stigma attached to it. But individuals with BPD suffer terribly and a significant proportion die by suicide and engage in nonsuicidal self-injury. The aim of this primer on BPD is to fill this void and provide clinicians with an accessible, easy-to-use, clinically oriented, evidenced-based guide for early-stage BPD. We present the most up to date data about BPD by leading experts in the field in a format accessible to trainees and professionals working with individuals with BPD and their family members. The volume is comprehensive and covers the etiology of BPD, its clinical presentation and comorbid disorders, genetics and neurobiology of BPD, effective treatment approaches to BPD, the role of advocacy, and the treatment of special subpopulations (e.g., forensic) in the clinical management of BPD.


2017 ◽  
Vol 12 (1) ◽  
pp. 217-228 ◽  
Author(s):  
Daniel Vega ◽  
Pablo Ripollés ◽  
Àngel Soto ◽  
Rafael Torrubia ◽  
Joan Ribas ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Frank D. Buono ◽  
Kaitlyn Larkin ◽  
David Rowe ◽  
M. Mercedes Perez-Rodriguez ◽  
Matthew E. Sprong ◽  
...  

Treatment of borderline personality disorder (BPD) with comorbid substance use disorder can be challenging due to symptom overlap and limited assessment methods. Preliminary evidence has shown promising effectiveness of dialectical behavioral therapy (DBT) for BPD with comorbid substance use disorders. The current study compared the benefits of a 28-day transitional DBT treatment program for individuals with BPD with and without substance use disorders through evaluating the changes in coping skills, generalized anxiety, and depression symptom scales at admission and discharge. A total of 76 patients were split into two groups: Group 1 consisted of individuals with BPD without substance use disorders (n = 41), and Group 2 involved individuals with BPD and a substance use disorder (SUD) (n = 35). A univariate general linear model showed significant differences between the two groups in improvement of coping skills and depressive symptoms. After a 28-day transitional DBT treatment program there were significant decreases from severe to moderate depression scores in both groups. Our findings support the effectiveness of DBT treatment in patients with comorbid BPD and SUD.


Sign in / Sign up

Export Citation Format

Share Document